In this study, we noticed that TP53 mutant EC showed abundant infiltration of CD8+ PD-1+ T cells in the tumor parenchyma and a high proportion of CD8+ T cells with PD-1 expression in the tumor mesenchyme, indicating unfavorable clinical outcomes of TP53 mutant EC. This evidence concerns the gene TP53 and neoplasm.